BLOOMIOS (BLMS) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 1 3 sessions, December 26, 2025 to August 20, 2026
- Largest daily move
- +200% close of July 7, 2026
Company Description
BLOOMIOS (OTC: BLMS) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $6.4K.
BLMS has gained 200.0% so far this year. The last closing price was $0.0003.
This page collects what Stock Titan holds for BLMS, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BLOOMIOS (BLMS) closed at $0.0003 on August 20, 2026. So far this year, the price has gained 200.0%.
BLMS Metrics & Rankings
Price returns through August 20, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
BLOOMIOS has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, management, conferences. View all BLMS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
BLMS Company Profile & Sector Positioning
BLOOMIOS (BLMS) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing BLMS often look at related companies in the same sector, including AVIVAGEN INC ORD (VIVXF), ITEM 9 LABS CORP (INLB), HALO COLLECTIVE INC (HCANF), BZAM LTD (BZAMF), and VERITAS FARMS INC (VFRM). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BLMS's relative position within its industry.